Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Polyhydroxyalkanoates (PHAs) are naturally occurring polyesters with promising drug delivery applications. Their hydrophobicity enables lipophilic drug encapsulation, enhancing bioavailability but limiting colloidal stability and physiological compatibility. Surfactants crucially improve the nanoparticle dimensional stability, dispersion, wettability of hydrophobic matrices, and cellular interaction, yet conventional surfactants require additional purification and may pose physiological risks. Self-surfactant systems offer a sustainable alternative. Therefore, this research proposes a green chemical modification of PHAs to develop self-surfactant systems. Hydrophilic groups were introduced onto a poly-3-hydroxybutyrate--3-hydroxyhexanoate (PHBHHx) backbone via amidation using choline taurinate ([Ch][Tau]), a biocompatible ionic liquid. This approach eliminates the need for toxic reagents and complex purification. By precisely controlling the PHBHHx/[Ch][Tau] molar ratio, amphiphilic structures with varying hydrophobic tail lengths were produced, as confirmed by infrared spectroscopy and chromatographic analysis. Nanoparticles were fabricated through the emulsion-solvent evaporation method and employed to encapsulate the lipophilic and antimicrobial agent usnic acid. Dynamic light scattering highlighted the obtainment of stable colloidal suspensions with dimensions of 40-160 nm. Biological evaluations demonstrated the antimicrobial efficacy against planktonic Newman strain and biofilm inhibition under fluidic conditions even for the unloaded nanoparticles. Additionally, the nanoparticles exhibited no cytotoxicity at concentrations ranging from 10 to 0.1 μg/mL while retaining antimicrobial activity, in contrast to the high cytotoxicity observed for free usnic acid. Overall, this approach offers a sustainable and scalable strategy to produce self-surfactant and intrinsically antimicrobial polymeric nanocarriers suitable for the systemic drug delivery of lipophilic compounds, smart implant coatings, and antibacterial topical formulations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12284855PMC
http://dx.doi.org/10.1021/acsabm.5c00676DOI Listing

Publication Analysis

Top Keywords

usnic acid
12
drug delivery
8
self-surfactant systems
8
antimicrobial
5
self-surfactant
4
self-surfactant poly-3hydroxybutyrate--3hydroxyhexanoate
4
poly-3hydroxybutyrate--3hydroxyhexanoate phbhhx
4
phbhhx preparation
4
preparation usnic
4
acid loaded
4

Similar Publications

Schiff bases have various pharmacological activities due to the azomethine (-C=N-) group. Usnic acid is the most famous lichen metabolite and it contains two carbonyl groups to synthesize the Schiff base derivatives with primary amines. Therefore, in the current study, the known Schiff base derivatives (2-5) of usnic acid (1) were synthesized to explore their antidiabetic, neuroprotective, antioxidant, antidepressant and anti-Parkinson's properties.

View Article and Find Full Text PDF

This study employed response surface methodology for the first-time optimization of the ultrasound-assisted extraction (UAE) of the total phenolic content (TPC) and ABTS from edible lichens, including , , , , and . Fourteen experimental points were generated using Design Expert Software, with the extraction temperature (25-40 °C), extraction time (5-20 min), and ethanol concentration (0-80%) as independent variables, and TPC and ABTS as dependent variables. The phenolic profile and mineral and antibacterial properties of the optimized lichen extracts were determined.

View Article and Find Full Text PDF

Chirality plays a key role in the effectiveness and toxicity of bioactive compounds. Usnic acid (UA), a lichen metabolite, exists as two enantiomers. Despite numerous studies on its biological properties, enantioselective aspects remain poorly recognized.

View Article and Find Full Text PDF

The prevalence of human fungal infections (FIs) is rapidly increasing worldwide, posing substantial challenges to public health. The underestimation of FIs risk led to a limited knowledge of the fungal pathogenicity and a concomitant paucity of antimycotic drugs that are increasingly unable to effectively address resistance liabilities. The identification of innovative antifungal drugs is therefore an urgent need.

View Article and Find Full Text PDF

In the present study, we developed and validated three liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods for quantification of the agent OL9-116, a Tdp1 inhibitor based on usnic acid, in murine lungs, liver and kidney, respectively. Additionally, a semi-quantitative method was developed for quantification of the agent in the primary tumor node of Lewis lung carcinoma. Tissue samples were prepared using ultrasonic homogenization and QuEChERS methodology.

View Article and Find Full Text PDF